Your Brain on CVD and Diabetes Drugs

Moderator(s)

• 

  G. Caleb Alexander, MD

  Professor of Epidemiology and Medicine
  Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  Baltimore, United States
• 

  Mette Nørgaard, MD, PhD

  Chief consultant, professor
  Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
  Aarhus N, Denmark

Presentations:

• 1:00 PM – 1:15 PM CEST

  The association between exposure to GLP-1 receptor agonists and risk of suicide-related and self-harm-related events in diabetic patients from the UK general practice IQVIA Medical Research Data (IMRD) database
  

  Presenting Author: Andrei Barbulescu, PhD (he/him/his) – European Medicines Agency

  Co-Author: María Clara Restrepo-Méndez, PhD – European Medicines Agency

  Co-Author: Daniel R. Morales, PhD – European Medicines Agency

  Co-Author: Robert Flynn, PhD – European Medicines Agency, University of Dundee
• 1:15 PM – 1:30 PM CEST

  Risk of suicidal attempt and GLP-1RAs in type 2 diabetes population in Taiwan: a case-crossover and case-case-time-control study
  

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan

  Presenting Author: Chris Tzu-Ting Su, PharmD – 1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Avery Shuei-He Yang, MClinicpharm – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan
• 1:30 PM – 1:45 PM CEST

  Dementia Associated With Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Study
  

  Presenting Author: Bin Hong – Sungkyunkwan University

  Co-Author: Sungho Bea, PharmD, PhD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

  Co-Author: Hwa Yeon Ko, PharmD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea

  Co-Author: Woo Jung Kim – 3Department of Psychiatry, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea

  Co-Author: Young Min Cho, MD, PhD – Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea

  Co-Author: Ju-Young Shin, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
• 1:45 PM – 2:00 PM CEST

  Phosphodiesterase-5 inhibition and Alzheimer disease risk: A Mendelian randomization study
  

  Presenting Author: Marta Alcalde Herraiz – University of Oxford

  Co-Author: Junqing Xie, MBBS, MSc, DPhil (he/him/his) – University of Oxford

  Co-Author: Benjamin Woolf – University of Bristol

  Co-Author: James Yarmolinsky – University of Bristol

  Co-Author: Ioanna Tzoulaki – Imperial College London

  Co-Author: Dipender Gill – Imperial College London

  Co-Author: Daniel Prieto-Alhambra, MD, MSc, PhD (he/him/his) – University of Oxford

  Co-Author: Danielle Newby, PhD – University of Oxford
• 2:00 PM – 2:15 PM CEST

  Brain-penetrant calcium channel blockers for psychiatric use: revisiting the evidence for benefit
  

  Presenting Author: David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson

  Co-Author: Justin Bohn, ScD – Johnson & Johnson

  Co-Author: Michael Maher – Johnson & Johnson

  Co-Author: Amin Yakubu – Johnson & Johnson

  Co-Author: Dmytro Dymshyts – Johnson & Johnson

  Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson
• 2:15 PM – 2:30 PM CEST

  The use of brain-penetrant calcium channel blockers (BP-CCBs) and risk of suicidality and hospitalization among patients with neuropsychiatric disorders: a retrospective comparative cohort study
  

  Co-Author: Azza Shoaibi, PhD, MPH – Johnson & Johnson

  Presenting Author: Justin Bohn, ScD – Johnson & Johnson

  Co-Author: David M. Kern, PhD, MS (he/him/his) – Johnson & Johnson

  Co-Author: Michael Maher – Johnson & Johnson

  Co-Author: Amin Yakubu – Johnson & Johnson

  Co-Author: Dmytro Dymshyts – Johnson & Johnson